Stochastic effects of radiation: Rad Tech

Watch video only
. Stochastic effects of radiation are delayed.
Probability-based effects associated with ionizing radiation exposure. In diagnostic imaging, these effects matter because these exposures are often low dose, low linear energy transfer, meaning the X-rays deposit energy sparsely and in small amounts and are delivered intermittently over time.
For radiation protection, the linear non-threshold or LNT model assumes that any dose carries some risk. As dose increases, probability increases, but severity does not.
As a radiologic technologist, understanding the epidemiologic evidence about stochastic effects helps inform radiation protection guidelines for medical imaging personnel and patients.
According to the LNT model, the stochastic dose response relationship is linear and is represented by a straight line with no threshold.
In other words, no radiation dose is considered completely risk-free. A higher dose may increase the chance that cancer develops, but it does not determine how aggressive that cancer will be.
This differs from tissue reactions such as radiation-related skin injuries. Tissue reactions have a dose threshold, and severity increases above it.
Because stochastic effects are uncommon, delayed, and indistinguishable from conditions arising without radiation, epidemiology studies are used to examine health patterns across populations.
Gathering epidemiologic evidence involves comparing exposed populations with similar comparison groups and following outcomes over time.
Interpretation can be difficult because stochastic effects are rare and delayed. Individual doses may be uncertain, and other risk factors can influence outcomes.
For example, after the Three Mile Island nuclear reactor accident in 1979, estimated radiation doses to the surrounding population were low, making it difficult to detect a small increase in cancer risk.
However, after the Chernobyl nuclear power plant accident in 1986, thyroid cancer was identified as radiation associated, while other late effects remained uncertain.
A series of reports on the biologic effects of ionizing radiation, or BEIR for short, synthesized evidence from many studies to inform radiation protection recommendations.
Because radiation induced effect usually can't be identified in one person, risk is estimated by comparing populations of exposed groups by calculating relative risk, excess risk, and attributable risk.
Relative risk compares the observed frequency of a radiation induced effect in an exposed group with the expected frequency in a comparison group or an unexposed group.
A value of one means there is no difference. A value above one means the effect is more common in the exposed group.
A value below one does not prove a protective effect from low dose radiation. Instead, it may reflect chance, a small sample size, or differences between study groups.
Because protective effects from low dose radiation have not been proven, imaging professionals continue to follow AARA, or as low as reasonably achievable.
Now to calculate relative risk, let's use a teaching example based on an exposed population. Suppose there are 227 leukemia cases among 100,000 exposed people compared to 150 cases with 100,000 people in the general unexposed population.
To calculate the relative risk, the observed number is divided by the expected number, so 227 is divided by 150. This equals 1.51, which means the exposed group has about 1.5 times the risk of the unexposed group.
The same data can be used to calculate excess risk, which is the observed number of cases minus the expected number of cases.
In this example, 227 leukemia cases were observed, while 150 were expected. Subtracting 150 from 227 gives 77 excess cases per 100,000 people, meaning 77 cases above the expected number in the comparison population.
Attributable risk estimates the additional number of cases associated with a specific radiation dose in a defined population.
For example, suppose 3 excess leukemia cases occur each year among 100,000 people who received an average dose of 20 mg.
Start by expressing the same rate for 1 million people. 1 million is 10 times larger than 100,000, so 3 cases become 30 cases.
That gives 30 excess cases per 1 million people per 20 mg each year. Next, express the risk per 10 mg because 10 mg is half of 20 mg, and the calculation assumes a linear relationship.
The estimated number of cases is also cut in half. From 30 to 15, the attributable risk is therefore 15 excess leukemia cases per 1 million people per 10 mg each year.
Exposure to ionizing radiation can increase the probability of malignancy. Studies of Hiroshima and Nagasaki survivors who received acute exposures to radiation showed that leukemia occurred more often than expected after a latent period of about 4 to 7 years, then peaked and gradually declined.
The at-risk period, which is the time after exposure when excess cases may appear, is about 20 years for leukemia, but may extend throughout life for other radiation-induced cancers.
These findings describe an increased probability across a population, not certainty, for an individual person. There are also some examples of exposed populations that provide evidence for radiation-related solid cancers.
Thyroid cancers were observed years after infants received radiation treatment for thymic enlargement, which exposed nearby thyroid tissue.
Likewise, bone cancers occurred among watch dial painters who ingested radium containing paint. Radium was ingested when the workers shaped paintbrush tips with their lips or tongue while painting fine lines on the watch details.
Now to estimate the total risk of malignancy, researchers combine evidence for leukemia and many types of solid cancer, such as cancers of the thyroid, breast, lung, bone and liver.
They compare the numbers of cancers observed in exposed populations with the numbers expected without radiation exposure while considering the estimated dose and how long each population was followed because cancers have different latent and at-risk periods, these studies may continue for decades.
The resulting estimate describes the overall probability of radiation-related malignancy across a population, not the cause of a specific cancer in an individual.
Radiation effects on reproduction are a common concern. High dose exposure to the ovaries or testes can impair fertility, but this is a tissue reaction, not a stochastic effect.
Additionally, low dose occupational exposure has not been shown to reduce fertility among radiologic technologists. During pregnancy, risk depends on the absorbed dose and the stage of fetal development.
At high doses, prenatal exposure can cause tissue reactions such as pregnancy loss, congenital abnormalities, impaired growth, or neurodevelopmental injury.
However, these effects are not expected from most properly performed diagnostic examinations because prenatal doses are usually far lower.
Prenatal exposure may also increase the probability of childhood cancer, which is a stochastic effect. When pregnancy is known or possible, imaging professionals should support screening, exam justification, and dose optimization.
The genetic effects of radiation can occur if radiation alters DNA in a germ cell, and that change is transmitted to a future generation.
Most of this evidence comes from studies in mice and fruit flies, and heritable effects have not been demonstrated in humans, including descendants of atomic bomb survivors.
Even so, protection models treat these as a possible stochastic risk. Animal data suggests that mutation frequency rises with dose, while predicted risk at diagnostic imaging levels is very low due to low doses and efficient cellular DNA repair mechanisms.
This uncertainty supports limiting unnecessary radiation exposure. All right, as a quick recap, stochastic effects are delayed probability-based effects for radiation protection.
The LNT model assumes there is no threshold, meaning that any amount of radiation, no matter how small, carries some risk proportional to the dose.
Dose changes probability but not severity. This contrasts with tissue reactions which have a threshold and severity increases above it.
Because radiation-induced cancer generally can't be distinguished from cancer that occurs spontaneously, researchers use epidemiologic studies and population risk estimates.
Relative risk compares frequencies. Excess risks count cases above the expected number.
And attributable risk relates additional cases to dose. Leukemia and solid cancers have a latent period.
High dose exposure can affect fertility or prenatal development through tissue reactions, while prenatal cancer risk and possible heritable effects are stochastic.
The Alara principle guides imaging professionals to keep radiation exposure as low as reasonably achievable while maintaining diagnostic